Health news
In patients with severe hypertriglyceridemia (HTG), the use of ω-3 phospholipid/free fatty acid (PL/FFA)—a novel krill oil–derived ω-3 formulation—reduced triglyceride (TG) levels. Study results were published in JAMA Network Open. The investigators sought to establish…
Off-label use of cardiovascular (CV) drugs in home therapy is common for children with congenital or acquired heart disease, according to a study published in The American Journal of Cardiology. Researchers reviewed the records of…
The Food and Drug Administration (FDA) has responded to a health claim petition submitted on behalf of The Center for Magnesium Education and Research requesting that the Agency authorize a health claim characterizing the relationship…
Lipoprotein(a) (Lp[a]) has been proven to be a potent, common, independent risk for atherosclerotic cardiovascular disease (ASCVD) and calcific aortic stenosis (CAS). Recent reviews summarize how its complex molecular structure is uniquely suited to initiate…
The Mediterranean Diet was picked as the best diet overall for 2022, according to new rankings released by US News and World Report. An expert panel assessed 40 diets to come up with the final…
The Food and Drug Administration (FDA) has approved Leqvio® (inclisiran) as an adjunct to diet and maximally tolerated statin therapy for the treatment of heterozygous familial hypercholesterolemia (HeFH) or clinical atherosclerotic cardiovascular disease (ASCVD) in…
The American Heart Association (AHA) released 2021 dietary guidelines, published in Circulation, aimed at improving cardiovascular health. The scientific statement supersedes the AHA’s 2006 guidelines about diet and lifestyle. The updated recommendation emphasizes the importance…
Abuse during childhood could have negative cardiometabolic outcomes later in life, according to study results published in the Journal of the American Heart Association. Data were sourced from the Avon Longitudinal Study of Parents and…
The Food and Drug Administration (FDA) has approved Xarelto® (rivaroxaban) for 2 new pediatric indications: treatment of venous thromboembolism (VTE) and reduction in the risk of recurrent VTE in patients from birth to less than…
The Food and Drug Administration (FDA) has granted 510(k) clearance to the geko device for increasing microcirculatory blood flow in lower limb soft tissue of patients with venous insufficiency and/or ischemia. The neuromuscular stimulation device…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021